John McKnight sold $1.1M of DORM
President, Heavy Duty at Dorman Products, Inc.. 8,185 shares at an average of $139.34, traded Dec 3, 2024, filed Dec 5, 2024.
Score components
- +20RolePresident
- +25Trade size$1.1M at market
- +20Share of holdings soldSold 54% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -6.6%, 3m -7.6%, 6m -8.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-24-050092, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 3, 2024 | MOption exercise Common Stock | +2,912 | $61.68 | $180k | 15,139 | Dec 5, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stock | -2,042 | $139.13 | $284k | 13,097 | Dec 5, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stock | -870 | $139.92 | $122k | 12,227 | Dec 5, 2024 |
| Dec 3, 2024 | MOption exercise Common Stock | +1,246 | $96.36 | $120k | 13,473 | Dec 5, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stock | -1,146 | $139.17 | $159k | 12,327 | Dec 5, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stock | -100 | $140.11 | $14k | 12,227 | Dec 5, 2024 |
| Dec 3, 2024 | MOption exercise Common Stock | +702 | $91.28 | $64k | 12,929 | Dec 5, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stock | -581 | $139.10 | $81k | 12,348 | Dec 5, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stock | -121 | $139.72 | $17k | 12,227 | Dec 5, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stock | -2,280 | $139.10 | $317k | 9,947 | Dec 5, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stock | -1,045 | $140.02 | $146k | 8,902 | Dec 5, 2024 |
| Dec 3, 2024 | MOption exercise Employee Stock Option (right to buy)derivative | -2,912 | $0.00 | $0 | 0 | Dec 5, 2024 |
| Dec 3, 2024 | MOption exercise Employee Stock Option (right to buy)derivative | -1,246 | $0.00 | $0 | 1,246 | Dec 5, 2024 |
| Dec 3, 2024 | MOption exercise Employee Stock Option (right to buy)derivative | -702 | $0.00 | $0 | 2,109 | Dec 5, 2024 |
Related signals
Other insiders at Dorman Products, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 13Weak | Dorman Products, Inc. | Donna M. Long SVP, CIO | $99k 734 shares | -4% | |
| 36Weak | Dorman Products, Inc. | Gregory C. Bowen VP, Chief Accounting Officer | $512k 3,531 shares | -40% | |
| 5Weak | Dorman Products, Inc. | Donna M. Long SVP, CIO | $98k 947 shares | -5% | |
| 5Weak | Dorman Products, Inc. | Donna M. Long SVP, CIO | $100k 812 shares | -4% | |
| 38Weak | DORMsell Dorman Products, Inc. | John McKnight President, Heavy Duty | $258k 2,000 shares | -18% | |
| 35Weak | DORMsell Dorman Products, Inc. | John McKnight President, Heavy Duty | $640k 4,898 shares | -31% | |
| 67Notable | DORMsell Dorman Products, Inc. | David Hession SVP and CFO | $1.7M 12,493 shares | -69% | |
| 18Weak | DORMsell Dorman Products, Inc. | Gregory C. Bowen VP, Chief Accounting Officer | $237k 1,453 shares | -24% | |
| 7Weak | Dorman Products, Inc. | Donna M. Long SVP, CIO | $182k 1,213 shares | -6% | |
| 5Weak | Dorman Products, Inc. | Donna M. Long SVP, CIO | $100k 820 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.